Skip to content

ABSOLUTE-PET study: Validation of Invasive Absolute Quantification of Coronary Microcirculatory Resistance against [15O]H2O Myocardial Perfusion Positron Emission Tomography

ABSOLUTE-PET study: Validation of Invasive Absolute Quantification of Coronary Microcirculatory Resistance against [15O]H2O Myocardial Perfusion Positron Emission Tomography - ABSOLUTE-PET

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
NL-OMON
Registry ID
NL-OMON47124
Enrollment
26
Registered
2017-03-20
Start date
2017-03-31
Completion date
Unknown
Last updated
2024-04-15

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Coronary microvascular dysfunction dysfunction of the small vessels in the heart

Interventions

None listed

Sponsors

Vrije Universiteit Medisch Centrum
Lead Sponsor

Eligibility

Age
18 Years to 99 Years

Inclusion criteria

Inclusion criteria: * Stable 1 or 2 vessel ischemic heart disease with at least 1 unobstructed reference coronary artery, where at least 1 coronary artery with a stenosis and 1 reference coronary artery both subtend 10% or more of the left ventricle as estimated by coronary computed tomography angiography (CCTA) * Age at least 18 years * Presence of a segment of at least 3 cm without major side branches proximal to the stenosis and in the reference coronary artery a segment with a length of at least 3 cm without major side branches has to be present

Exclusion criteria

Exclusion criteria: * Pregnancy * Uncorrected severe valvular heart disease * Non-ischemic cardiomyopathy with left ventricular ejection fraction

Design outcomes

Primary

MeasureTime frame
Correlation between [15O]H2O PET perfusion imaging MR and invasive MR.

Secondary

MeasureTime frame
To investigate whether saline infusion and adenosine infusion produce coronary microvascular vasodilation equally. We expect this to be true, and if this is the case, adenosine administration is no longer needed for this measurement.

Countries

Netherlands

Outcome results

None listed

Source: NL-OMON (via WHO ICTRP)